Skip to main content

Peer Review reports

From: Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan

Original Submission
10 May 2019 Submitted Original manuscript
6 Jun 2019 Reviewed Reviewer Report - Wafaa Al-Qabandi
3 Jul 2019 Reviewed Reviewer Report - Alan Ngo
13 Jul 2019 Reviewed Reviewer Report - Ryuta Nishikomori
11 Sep 2019 Author responded Author comments - Hitoshi Tajiri
Resubmission - Version 2
11 Sep 2019 Submitted Manuscript version 2
17 Sep 2019 Author responded Author comments - Hitoshi Tajiri
Resubmission - Version 3
17 Sep 2019 Submitted Manuscript version 3
Publishing
20 Sep 2019 Editorially accepted
13 Oct 2019 Article published 10.1186/s12887-019-1739-5

You can find further information about peer review here.

Back to article page